<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Delta Like Non-Canonical Notch Ligand 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>DLK1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Delta Like Non-Canonical Notch Ligand 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>14q32.12</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[1749](https://www.ncbi.nlm.nih.gov/gene/1749)</td></tr>
<tr><td><strong>OMIM</strong></td><td>176290</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000176358</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[O00548](https://www.uniprot.org/uniprot/O00548)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Epidermal Growth Factor Family</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), Cancer, Angelman Syndrome</td></tr>
</table>
</div>
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Delta Like Non-Canonical Notch Ligand 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>DLK1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Delta Like Non-Canonical Notch Ligand 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>14q32.12</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[1749](https://www.ncbi.nlm.nih.gov/gene/1749)</td></tr>
<tr><td><strong>OMIM</strong></td><td>176290</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000176358</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[O00548](https://www.uniprot.org/uniprot/O00548)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Epidermal Growth Factor Family</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), Cancer, Angelman Syndrome</td></tr>
</table>
</div>
DLK1 (Delta-Like 1 Homolog), also known as PREF-1 (Pre-Adipocyte Factor 1), is a member of the epidermal growth factor (EGF)-like family that functions as a non-canonical Notch ligand and regulator of cell fate decisions. Located on chromosome 14q32.12 with NCBI Gene ID 1749, DLK1 is an imprinted gene expressed exclusively from the paternal allele["@baladron2002"][@laborda2016].
DLK1 has garnered attention in neurobiology due to its critical roles in neural development, synaptic plasticity, and potential involvement in neurodegenerative diseases. The protein functions as both a signaling molecule and a regulated protease substrate, producing soluble fragments that have distinct biological activities["@sul2004"][@evangelisti2009].
The DLK1 gene spans approximately 16 kb on chromosome 14q32.12 within a imprinted domain and consists of 8 exons. The gene produces multiple transcript variants encoding proteins of varying lengths, with the major isoform being a 396-amino acid transmembrane protein.
The DLK1 protein exhibits characteristic EGF-family architecture:
DLK1 undergoes extensive proteolytic processing:
DLK1 exhibits specific expression patterns:
| Tissue | Expression Level | Function |
|--------|------------------|----------|
| Brain | High | Neurodevelopment, plasticity |
| Adrenal gland | High | Neuroendocrine function |
| Adipose tissue | Moderate | Adipogenesis inhibition |
| Muscle | Moderate | Regeneration |
| Liver | Low | Metabolic regulation |
In the central nervous system, DLK1 is expressed in:
DLK1 functions as a Notch ligand[@baladron2002][@rossi2014]:
DLK1 controls cell fate in multiple contexts[@sul2004]:
DLK1 plays critical roles in brain development[@evangelisti2009]:
DLK1 is implicated in synaptic function[@mendez2018]:
DLK1 has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis[@fayed2017][@schröder2018]:
DLK1 has been studied in:
| Condition | Finding |
|-----------|---------|
| Parkinson's Disease | Altered expression in substantia nigra |
| Multiple Sclerosis | Impaired remyelination |
| Brain Aging | Declines with age |
| Neuroinflammation | Regulates microglial function |
DLK1 shows potential as a biomarker:
Targeting DLK1 could provide benefits:
| Approach | Rationale | Status |
|----------|-----------|--------|
| Antibody therapy | Neutralize soluble DLK1 | Preclinical |
| Gene therapy | Modulate expression | Experimental |
| Small molecules | Inhibit proteolytic processing | Early development |
DLK1 interacts with:
DLK1 affects:
The following diagram shows the key molecular relationships involving DLK1 Gene discovered through SciDEX knowledge graph analysis: